This study validates a deep learning model using resting-state EEG to compute brain age gap (BAG), establishing it as a robust biomarker for accelerated neuroaging and preclinical cognitive decline.
Yale scientists have identified tunneling nanotubes as a direct interneuronal route for α-synuclein transfer, offering a novel therapeutic target for halting Parkinson's disease progression.
A hidden threshold in tau protein spread determines whether an individual crosses into irreversible cognitive decline, offering a new predictive and therapeutic window for Alzheimer's disease.
Exploring health mechanisms and lifestyle strategies.
This paper examines a deep learning framework that estimates brain age from resting-state fMRI with ±2.3-year accuracy, establishing brain-age gap as a robust biomarker for accelerated neuroaging and cognitive decline risk.
A novel immunotherapeutic approach demonstrates that transcriptional reprogramming of microglia from a pro-inflammatory to a phagocytic state markedly reduces amyloid burden and rescues cognitive deficits in preclinical Alzheimer's models.
Harvard and MIT researchers reveal that neuronal activation requires transient, topoisomerase IIβ-mediated DNA double-strand breaks at specific promoter regions to relieve topological constraints and initiate immediate early gene expression—a process whose dysregulation underlies neurodevelopmental disorders and age-related cognitive decline.
A newly identified nuclear lamina protein, Lamin B1, acts as a genomic gatekeeper in neurons, anchoring damaged DNA and recruiting repair machinery to confer resilience against Alzheimer's pathology.
New research from Harvard and Stanford shows the brain achieves true multitasking not by parallel processing, but by dynamically rewiring dual circuits for near-instantaneous task switching.
A data-driven analysis of why U.S. middle-aged adults exhibit accelerated biological aging, linking metabolic dysfunction, chronic low-grade inflammation, and telomere attrition to a systemic “breaking point” before age 60.
This paper synthesizes recent peer-reviewed evidence from Harvard, Stanford, and *Nature Neuroscience* to demonstrate that dreams are a non-random, active neurobiological process of memory reclassification, emotional desensitization, and cognitive map reconstruction.
A longitudinal cohort study of 1,440 nonagenarians demonstrates that targeted cognitive training combined with metabolic optimization can reverse age-related white matter degradation and improve executive function well into the 10th decade.
A new neuroimaging study overturns the classical “language organ” model, showing that adult speech learning relies on real-time prediction error signals between motor and auditory cortices, not innate grammatical modules.
Yale researchers identify tunneling nanotubes as the direct intercellular route for α-synuclein transfer, explaining the stereotypical spread of Parkinson’s pathology along neural circuits.
A study published in *Nature Neuroscience* identifies a previously overlooked recessive gene mutation that disrupts the endoplasmic reticulum–mitochondria axis, providing the long-sought molecular cause of a rare neurodegenerative disorder.
This review demonstrates that a popular over-the-counter brain supplement is significantly linked to increased all-cause mortality in men, driven by mechanisms involving mitochondrial stress and epigenetic dysregulation.
This paper reviews the molecular mechanisms of autophagy and presents a daily protocol combining intermittent fasting, exercise, and natural compounds to activate AMPK-mTOR pathways for longevity.
Drawing on recent clinical data from Harvard and Stanford, this paper reveals how photoperiod and gut microbiota synergistically repair deep sleep via the melatonin–short-chain fatty acid axis, and provides actionable circadian reset protocols.
Exploring health mechanisms and lifestyle strategies.
This paper reviews a recently identified brainstem-to-cortex circuit that, during slow-wave sleep, simultaneously triggers muscle protein synthesis, adipose tissue lipolysis, and glymphatic clearance of neurotoxic metabolites.
A mechanistic review of how the circadian clock gates mitochondrial autophagy via NAD+/SIRT1, and a time-restricted intervention protocol to restore slow-wave sleep.
A newly identified mechanism suggests Alzheimer's disease is triggered not by amyloid-beta accumulation, but by an age-related loss of a specific lipid-processing enzyme in microglia, initiating a cascade of neuroinflammation and tau pathology.
Exploring health mechanisms and lifestyle strategies.
A landmark study in *Nature Neuroscience* demonstrates that open-label placebo—administered with full transparency—can enhance working memory via prefrontal-hippocampal circuit activation, offering a novel non-pharmacological avenue for cognitive decline.